• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Crystallization and preliminary X-ray diffraction analysis of the complex of a human anti-ephrin type-A receptor 2 antibody fragment and its cognate antigen.人抗A类 Ephrin 受体 2 抗体片段与其同源抗原复合物的结晶及初步 X 射线衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Jun 1;66(Pt 6):730-3. doi: 10.1107/S1744309110015861. Epub 2010 May 29.
2
Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-alpha toxin antibody fragment and alpha toxin.人抗α毒素抗体片段与α毒素复合物的结晶及初步X射线衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Mar 1;69(Pt 3):302-5. doi: 10.1107/S1744309113002881. Epub 2013 Feb 23.
3
Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-interferon antibody fragment and human interferon alpha-2A.人抗干扰素抗体片段与人干扰素α-2A复合物的结晶及初步X射线衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jan 1;65(Pt 1):14-6. doi: 10.1107/S1744309108037925. Epub 2008 Dec 25.
4
Crystallization and preliminary diffraction studies of prostaglandin E2-specific monoclonal antibody Fab fragment in the ligand complex.配体复合物中前列腺素E2特异性单克隆抗体Fab片段的结晶及初步衍射研究
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Nov 1;64(Pt 11):1027-30. doi: 10.1107/S174430910803131X. Epub 2008 Oct 28.
5
Crystallization of BMP receptor type IA bound to the antibody Fab fragment AbD1556.与抗体Fab片段AbD1556结合的IA型骨形态发生蛋白受体的结晶。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Aug 1;66(Pt 8):964-8. doi: 10.1107/S1744309110024681. Epub 2010 Jul 29.
6
Purification, crystallization and X-ray diffraction analysis of a recombinant Fab that recognizes a human blood-group antigen.一种识别人类血型抗原的重组Fab片段的纯化、结晶及X射线衍射分析
Acta Crystallogr D Biol Crystallogr. 2004 Apr;60(Pt 4):788-91. doi: 10.1107/S0907444904002963. Epub 2004 Mar 23.
7
Structural and functional characterization of an agonistic anti-human EphA2 monoclonal antibody.一种激动型抗人 EphA2 单克隆抗体的结构和功能表征。
J Mol Biol. 2011 Oct 21;413(2):390-405. doi: 10.1016/j.jmb.2011.08.018. Epub 2011 Aug 16.
8
Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009.癌分化抗原间皮素的抗体识别片段与治疗性抗体MORAb-009复合物晶体的表征
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Aug 1;68(Pt 8):950-3. doi: 10.1107/S1744309112028229. Epub 2012 Jul 31.
9
Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.抗肽Fab 50.1与HIV-1 gp120主要中和决定簇的肽复合物的结晶、序列及初步晶体学数据。
Proteins. 1992 Dec;14(4):499-508. doi: 10.1002/prot.340140410.
10
Crystallization and preliminary X-ray data for the human transthyretin-retinol-binding protein (RBP) complex bound to an anti-RBP Fab.与抗视黄醇结合蛋白(RBP)Fab片段结合的人甲状腺素运载蛋白-视黄醇结合蛋白(RBP)复合物的结晶及初步X射线数据。
Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):276-8. doi: 10.1107/S0907444998007860. Epub 1999 Jan 1.

引用本文的文献

1
Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology.真核细胞中重组糖蛋白的表达:迈向结构生物学的综合方法。
Curr Opin Struct Biol. 2013 Jun;23(3):345-56. doi: 10.1016/j.sbi.2013.04.003. Epub 2013 Apr 25.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-interferon antibody fragment and human interferon alpha-2A.人抗干扰素抗体片段与人干扰素α-2A复合物的结晶及初步X射线衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jan 1;65(Pt 1):14-6. doi: 10.1107/S1744309108037925. Epub 2008 Dec 25.
3
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.一种靶向 EphA2 的人源抗体 - 药物偶联物在体内可抑制肿瘤生长。
Cancer Res. 2008 Nov 15;68(22):9367-74. doi: 10.1158/0008-5472.CAN-08-1933.
4
Structural characterization of a mutated, ADCC-enhanced human Fc fragment.一种突变的、增强ADCC作用的人Fc片段的结构表征
Mol Immunol. 2008 Apr;45(7):1872-82. doi: 10.1016/j.molimm.2007.10.042.
5
Regulation of angiogenesis by Eph-ephrin interactions.Eph-ephrin相互作用对血管生成的调控。
Trends Cardiovasc Med. 2007 Jul;17(5):145-51. doi: 10.1016/j.tcm.2007.03.003.
6
Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients.p53缺失和EphA2过表达预示卵巢癌患者预后不良。
Cancer Biol Ther. 2007 Feb;6(2):288-9. doi: 10.4161/cbt.6.2.4024. Epub 2007 Feb 10.
7
Bidirectional ephrin/Eph signaling in synaptic functions.双向 Eph 受体配体/Eph 信号在突触功能中的作用
Brain Res. 2007 Dec 12;1184:72-80. doi: 10.1016/j.brainres.2006.11.033. Epub 2006 Dec 12.
8
Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system.ephrin和Eph受体酪氨酸激酶家族在血管生成及心血管系统发育中的作用。
J Pathol. 2006 Mar;208(4):453-61. doi: 10.1002/path.1937.
9
The role of ephrins and Eph receptors in cancer.Ephrin 与 Eph 受体在癌症中的作用。
Cytokine Growth Factor Rev. 2004 Dec;15(6):419-33. doi: 10.1016/j.cytogfr.2004.09.002.
10
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.EphA2过表达与食管鳞状细胞癌的不良预后相关。
Int J Cancer. 2003 Feb 20;103(5):657-63. doi: 10.1002/ijc.10860.

人抗A类 Ephrin 受体 2 抗体片段与其同源抗原复合物的结晶及初步 X 射线衍射分析

Crystallization and preliminary X-ray diffraction analysis of the complex of a human anti-ephrin type-A receptor 2 antibody fragment and its cognate antigen.

作者信息

Oganesyan Vaheh, Damschroder Melissa M, Phipps Sandrina, Wilson Susan D, Cook Kimberly E, Wu Herren, Dall'Acqua William F

机构信息

Department of Antibody Discovery and Protein Engineering, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA.

出版信息

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Jun 1;66(Pt 6):730-3. doi: 10.1107/S1744309110015861. Epub 2010 May 29.

DOI:10.1107/S1744309110015861
PMID:20516612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2882782/
Abstract

The recombinant N-terminal domain of human ephrin type-A receptor 2 (rEphA2) has been crystallized in complex with the recombinantly produced Fab fragment of a fully human antibody (1C1; IgG1/kappa). These are the first reported crystals of an ephrin receptor bound to an antibody. The orthorhombic crystals belonged to space group C222(1) (the 00l reflections obey the l = 2n rule), with unit-cell parameters a = 78.93, b = 120.79, c = 286.20 A. The diffraction of the crystals extended to 2.0 A resolution. However, only data to 2.55 A resolution were considered to be useful owing to spot overlap caused by the long unit-cell parameter. The asymmetric unit is most likely to contain two 1C1 Fab-rEphA2 complexes. This corresponds to a crystal volume per protein weight (V(M)) of 2.4 A(3) Da(-1) and a solvent content of 49.5%. The three-dimensional structure of this complex will shed light on the molecular basis of 1C1 specificity. This will also contribute to a better understanding of the mechanism of action of this antibody, the current evaluation of which as an antibody-drug conjugate in cancer therapy makes it a particularly interesting case study.

摘要

人 EphA2 型受体的重组 N 端结构域(rEphA2)已与一种全人源抗体(1C1;IgG1/kappa)的重组 Fab 片段形成复合物并结晶。这些是首次报道的 Ephrin 受体与抗体结合的晶体。正交晶体属于空间群 C222(1)(00l 反射服从 l = 2n 规则),晶胞参数 a = 78.93、b = 120.79、c = 286.20 Å。晶体的衍射延伸至 2.0 Å 分辨率。然而,由于长晶胞参数导致的斑点重叠,仅 2.55 Å 分辨率的数据被认为是有用的。不对称单元很可能包含两个 1C1 Fab-rEphA2 复合物。这对应于每蛋白质重量的晶体体积(V(M))为 2.4 ų Da⁻¹,溶剂含量为 49.5%。该复合物的三维结构将阐明 1C1 特异性的分子基础。这也将有助于更好地理解该抗体的作用机制,目前将其作为癌症治疗中的抗体药物偶联物进行评估,使其成为一个特别有趣的案例研究。